» Authors » Mohammad Javad Nasiri

Mohammad Javad Nasiri

Explore the profile of Mohammad Javad Nasiri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 134
Citations 1590
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabaghian T, Kharazmi A, Omidi F, Hajikhani B, Tehrani S, Mardani S, et al.
Immun Inflamm Dis . 2025 Feb; 13(2):e70134. PMID: 39898621
Introduction: As the COVID-19 pandemic transitions, understanding the intricate dynamics of the disease becomes paramount. This systematic review explores the role of antiphospholipid antibodies in COVID-19, focusing on their potential...
2.
Razjouyan K, Babazadeh Dezfoly A, Davari Ashtiani R, Khademi M, Arabgol F, Nasiri M, et al.
Iran J Child Neurol . 2025 Feb; 19(1):25-35. PMID: 39896700
Objectives: Autism is determined by children's inability to communicate with others through language. More studies have shown that neurological soft signs (NSS) can be one of the symptoms of psychiatric...
3.
Khoshdel N, Noursalehigarakani M, Seghatoleslami Z, Hadavand F, Eghbal E, Nasiri M, et al.
Eur J Clin Microbiol Infect Dis . 2025 Jan; PMID: 39841366
Introduction: Ceftazidime-avibactam (CAZ-AVI) has emerged as a promising treatment option for Gram-negative infections, particularly those caused by CAZ-Non-Susceptible (NS) pathogens. This systematic review and meta-analysis aim to assess the efficacy...
4.
Sodeifian F, Kian N, Atefi A, Atefi A, Naserghandi A, Zangiabadian M, et al.
Respiration . 2024 Dec; :1-16. PMID: 39733773
Introduction: Lung cancer is a leading cause of cancer-related deaths worldwide, with rising incidence in resource-limited settings. Research suggests an increased risk of lung cancer in individuals with a history...
5.
Cheraghi M, Amiri M, Omidi F, Shahidi Bonjar A, Bakhshi H, Vaezi A, et al.
Eur Heart J Open . 2024 Dec; 4(6):oeae098. PMID: 39712649
Electronic cigarette (EC) is widely advertised as a safe alternative to traditional cigarette (TC). We aimed to investigate the cardiovascular effect of EC with/without nicotine compared with TC. We systematically...
6.
Khelghati F, Rahmanian M, Eghbal E, Seghatoleslami Z, Goudarzi M, Keramatinia A, et al.
New Microbes New Infect . 2024 Dec; 62:101533. PMID: 39639969
Introduction: Tuberculosis (TB) risk associated with tumor necrosis factor-alpha (TNF-α) antagonist therapy in patients with autoimmune diseases is a significant concern. This study aims to evaluate the risk of TB...
7.
Oraee S, Alinejadfard M, Golsorkh H, Sadeghian M, Fanaei M, Centis R, et al.
J Psychiatr Res . 2024 Nov; 180:371-379. PMID: 39522447
A large number of people worldwide grapple with Major Depressive Disorder (MDD), and a significant portion of them confront resistance to conventional antidepressant treatments. Esketamine, an innovative intervention, has garnered...
8.
Omidi F, Delkash P, Nasiri M, Mirsaeidi M
Curr Rheumatol Rev . 2024 Nov; PMID: 39513305
Background: Upadacitinib, a Janus kinase (JAK) inhibitor used in rheumatoid arthritis treatment, has prompted safety concerns due to potential cardiovascular adverse events. However, current evidence does not provide a definitive...
9.
Tysiac-Mista M, Tanasiewicz M, Amini S, Najary S, Baghani M, Eftekhar Ashtiani R, et al.
Arch Acad Emerg Med . 2024 Oct; 13(1):e11. PMID: 39465059
Introduction: Traumatic dental injuries (TDI) are a global public health concern, impacting individuals of various age groups. This systematic review aimed to consolidate current evidence on TDI prevalence, providing insights...
10.
Omidi F, Nasiri M, Sadeghi S
Glob Cardiol Sci Pract . 2024 Oct; 2024(4):e202429. PMID: 39351474
Introduction: Cardiovascular diseases (CVDs) pose a significant global health challenge and affect diverse populations. For conditions such as coronary artery disease, heart failure, and stroke prevalence, understanding the multifaceted factors...